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Objective: The aim of the present study was to assess whether the WASPLab
automation enables faster detection of vancomycin-resistant Enterococcus (VRE) on
chromogenic VRE-specific plates by shortening the incubation time.
Methods: Ninety different VRE culture negative rectal ESwab specimens were spiked
with various concentrations (ranging from 3 × 102 to 3 × 107 CFU/ml) of 10
Enterococcus faecium strains (vancomycin MICs ranging from 32 to >256 mg/l), 3
E. faecium VanB strains (vancomycin MICs: 4, 8, and 16 mg/l), and 2 E. faecium VanB
strains displaying vancomycin heteroresistance (vancomycin MICs: 64 and 96 mg/l).
Results: Besides the two strains exhibiting vancomycin heteroresistance, all the other
13 VRE strains included in this study were detected as early as 24 h on the WASPLab
even if the inoculum was low (3 × 103 CFU/ml). When the vancomycin MICs were high,
all strains were detected as early as at 18 h. However, 30 h was a conservative time point
for finalizing the analysis of chromogenic cultures.
Conclusion: These results suggested that the WASPLab automated incubation could
allow decreasing the initial incubation time to 18 h, followed by an intermediate time at
24 h and a final incubation period of 30 h for VRE culture screening, to deliver rapid results
without affecting the analytical sensitivity.
Keywords: Copan WASPLab, time to results, vancomycin-resistant Enterococcus, VRE, culture, screening,
chromogenic media
INTRODUCTION
Since the 1970’s, enterococci are considered as one of the common causes of hospital-acquired
infections. Several reasons have been advanced to explain why these pathogens are frequently
isolated in the hospital environment, including their capacity to acquire resistance to almost
all available antibiotics and their ability to survive for long periods on surfaces (Kramer
et al., 2006; Garcia-Solache and Rice, 2019). Enterococci are commensal colonizers of the
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gastrointestinal tract but they are involved in a variety of
serious nosocomial infections, such as urinary tract infections,
intraabdominal infections, bacteremia and endocarditis
(O’Driscoll and Crank, 2015; Shah et al., 2018). Until the
late eighties, vancomycin was considered as the only effective
antibiotic for the treatment of infections associated with
multidrug-resistant enterococci. This situation was challenged
by the report of the first case of a vancomycin resistant
Enterococcus (VRE) infection in 1988 (Uttley et al., 1988).
Vancomycin resistance is caused by the presence of the van
operon, carried on either a plasmid or the chromosome, and
appears to be inducible (Ahmed and Baptiste, 2018). Nowadays,
VRE are widespread and their prevalence can reach up to 35%
of all enterococci isolated, contingent upon the geographical
location (Werner et al., 2008; O’Driscoll and Crank, 2015).
Transmission from surface to person or from person-to-person
is a severe threat since the infections caused by VRE have
been linked to an increased mortality rate (Diazgranados et al.,
2005). The early identification of colonized patients by active
screening of high-risk patients remains the effective way to
prevent transmission, by enabling timely implementation of
adapted infection control measures and surveillance, especially
for vancomycin-resistant vanA/vanB types Enterococcus
faecium and Enterococcus faecalis (Vehreschild et al., 2018).
Nowadays, the majority of clinical microbiology laboratories
use chromogenic media to screen for the presence of VRE
in fecal or rectal swab specimens. However, plating and
interpreting bacterial growth on chromogenic VRE plates can
be time-consuming.
The main objective of this study was to assess whether the use
of the WASPLab automation allows shorter incubation times of
specific chromogenic plates and permits earlier identification of
colonized patients, as well as earlier confirmation of the absence
of carriage, both helping to prevent transmission and to reduce
unnecessary cohorting.
MATERIALS AND METHODS
Bacterial Strains
The 15 vancomycin-resistant E. faecium strains examined in
this study were taken from a collection of non-consecutive
clinical isolates identified at Geneva university hospitals
(HUG) and by the Swiss National Reference Centre for
Emerging Antibiotic Resistance (NARA). Table 1 depicts the
characteristics of these clinical strains. Vancomycin MICs were
determined by the gradient strip method (Etest, bioMérieux
Marcy l’Etoile, France) according to the manufacturer’s
instructions. Importantly, the gradient strip method (Etest)
or MIC Test Strip (Liofilchem, Italy) underestimates the
vancomycin MIC for E. faecalis and E. faecium strains carrying
the vanA/vanB genes but exhibiting low-level vancomycin
resistance (Eucast, 2018). The identification of the strains
was systematically confirmed by matrix-assisted desorption
ionization time-of-flight mass spectrometry (MALDI-TOF MS;
compass, Bruker Daltonics, Bremen, Germany) according to the
manufacturer’s instructions.
Preparation of the Spiked Samples
As the VRE prevalence in our institution is very low (about 1%
of all isolated Enterococcus), the specimens of this study were
constituted of 90 different VRE negative rectal ESwab (Copan,
Brescia, Italy) specimens spiked with various concentrations
(ranging from 3 × 102 to 3 × 107 CFU/ml) of the 15 VRE
strains included in this study. The final density was systematically
controlled by viable cell counting. We checked also if the CFUs
we retrieved on selective media corresponded to the actual
CFUs spiked.
The rectal ESwabs used in this study were referred to the
bacteriology laboratory at HUG, and validated as VRE negative
by culture. The chromogenic agar used in this study was
the chromID R© VRE (bioMérieux Marcy l’Etoile, France) that
contains 8 mg/l of vancomycin. Chromogenic VRE plates were
inoculated with 30µl of negative rectal ESwabs specimens spiked
with defined VRE concentrations ranging from 3 × 102 to 3 ×
107 CFU/ml for each of the 15 VRE strains analyzed in this study.
Sample Processing
In the absence of any enrichment, we determined the shortest
incubation times for (i) detecting, and (ii) ruling out the
presence of VRE, respectively, by performing time-series image
acquisition on the WASPLab (Copan WASP srl, Brescia Italy)
at sequential time points (18, 24, 30, 36, 40, and 48 h). For
each evaluated incubation time point, several high-resolution
digital images were acquired under different light and exposure
conditions according to manufacturer’s instructions. Growth
of VRE was defined by the presence of the specific VRE
color on chromID R© VRE, and was systematically quantified
on the WASPLab. Finally, we assessed the results obtained
by WASPLab automation against those obtained by WASP-
based inoculation followed by conventional incubation and
manual diagnostic which constitutes the routine method used in
our laboratory.
Population Analysis Profiling
Population analysis profiling (PAP) was performed using a
modified spotting method (Pfeltz et al., 2001). Briefly, a
suspension of each strain was adjusted to 2.0 McFarland and
serially 10-fold diluted to 10−7. All suspensions were spotted
using 10 µl droplets on Mueller Hinton agar and on plates
containing serial dilutions of vancomycin at concentrations
from 64 to 0.25 mg/l. Two replicates were performed. Colonies
were counted after 24 h of incubation at 37◦C. A strain was
identified as heteroresistant when the antibiotic exhibiting the
highest inhibitory effect was >8-fold higher than the highest
non-inhibitory concentration (El-Halfawy and Valvano, 2015).
RESULTS
As shown in Table 2, all the 60 negative rectal ESwabs
spiked with increasing concentrations of the 10 HUG VRE
strains (ranging from 3 × 102 to 3 × 107 CFU/ml) were
already detected positive at 18 h when the chromogenic
media was incubated on the WASPLab. No difference was
observed between 18, 24, 30, 36, 40, and 48 h for both,
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TABLE 1 | Characteristics of the Enterococcus faecium strains used in this study.
Strain ID, year of isolation,
patient gender, patient age
VAN MIC by
E-test
VAN MIC by
broth
micrcodilution
VAN (Disk
diffusion 5 µg)
Growth on BHIA
+ 6 mg/l VAN
Teicoplanin MIC
by E-test
Daptomycin
MIC by E-test
Linezolid MIC
by E-test
E. faecium VanB (NARA-89) 6 (R) 4 (S) R* + 0.38 (S) 1 (S) 0.75 (S)
E. faecium VanB (NARA-388) 6 (R) 16 (R) R* + 1.5 (S) 2 (S) 0.75 (S)
E. faecium VanB (NARA-490) 32 (R)** 64 (R) R* + 1 (S) 1.5 (S) 1 (S)
E. faecium VanB (NARA-491) 96 (R)** >64 (R) R* + 1 (S) 2 (S) 1 (S)
E. faecium VanB (NARA-492) 4 (S) 8 (R) R* + 0.75 (S) 3 (S) 0.75 (S)
E. faecium (2018, Female,
85 y) HUG
256 (R) >64 (R) R + 48 (R) 3 (S) 1 (S)
E. faecium (2018, Female,
68 y) HUG
256 (R) >64 (R) R + 1.5 (S) 3 (S) 1 (S)
E. faecium (2018, Female,
<1 y) HUG
256 (R) >64 (R) R + 12 (R) 2 (S) 0.75 (S)
E. faecium (2018, Female,
<1 y) HUG
>256 (R) >64 (R) R + 24 (R) 3 (S) 1 (S)
E. faecium (2018, Male,
30 y) HUG
32 (R) 64 (R) R + 1 (S) 2 (S) 1 (S)
E. faecium (2018, Male,
<1 y) HUG
256 (R) >64 (R) R + 16 (R) 3 (S) 1 (S)
E. faecium (2018, Male,
58 y) HUG
>256 (R) >64 (R) R + 96 (R) 4 (S) 0.5 (S)
E. faecium (2018, Male,
84 y) HUG
128 (R) >64 (R) R + 1 (S) 2 (S) 0.75 (S)
E. faecium (2018, Male,
90 y) HUG
48 (R) >64 (R) R + 0.75 (S) 2 (S) 0.75 (S)
E. faecium (2018, Female,
7 y) HUG
>256 (R) >64 (R) R + 64 (R) 8 (R) 0.75 (S)
VAN, Vancomycin; MIC, Minimum Inhibitory Concentration.
*Fuzzy zone edges, **Presence of a resistant heteropopulation.
R, resistant; S, susceptible.
Daptomycin MICs were interpreted according to CLSI breakpoints.
the identification and the quantification of VRE, despite
expected differences in the intensity of the specific color
and the size of the colonies. All these 10 VRE strains were
detected at 24 h by using WASP-based automated inoculation
coupled to conventional incubation and the manual diagnostic
method (Table 2).
As depicted in Figure 1A, NARA-490 and NARA-491 showed
the presence of distinct colonies growing within the inhibition
zone of the vancomycin indicating the presence of hetero-
resistant subpopulations. Hetero-resistance to vancomycin was
confirmed by population analysis profiles (Figure 1B). The
NARA-490 strain was detected positive at 18 h on the WASPLab
when the inoculum was equal or above 3 × 105 CFU/ml. In
contrast, when the inoculum was <3 × 105 CFU/ml, NARA-
490 was detected positive at 30 h on the WASPLab but only
at 48 h when incubating the chromID R© VRE plates using a
conventional incubator. Importantly, no growth was observed
when the inoculum was equal to or <3× 102 CFU/ml, even after
48 h of incubation on the WASPLab or using the conventional
incubator (Table 2). NARA-491 was detected positive at 18 h
on the WASPLab when the inoculum was equal or above 3 ×
104 CFU/ml and only at 30 h when the inoculum was lower
than 3 × 104 CFU/ml (Table 2). NARA-492 (vancomycin MIC
= 8 mg/l) was detected positive at 24 h on WASPLab but
not at 18 h when spiked at concentrations equal to or <3
× 106 CFU/ml. NARA-89 and NARA-388 were detected at
24 h of incubation on the WASPLab as compared to 48 h by
using WASP coupled to conventional incubation and manual
diagnostic. However, when the inoculum was equal to or higher
than 3 × 105 CFU/ml, the two strains were already detected
at 18 h.
DISCUSSION
The most prevalent glycopeptide resistance genotypes in
enterococci are vanA and vanB types. The increasing prevalence
of E. faecium strains resistant to vancomycin is linked to the
increasing rates of VRE in many European countries, with rates
ranging between <1% in the Nordic European countries to
more than 30% in Greece and Ireland (Werner et al., 2008).
In Switzerland, several hospitals have reported nosocomial VRE
outbreaks in the last few years (Thierfelder et al., 2012; Moulin
et al., 2018; Abdelbary et al., 2019; Niccolò et al., 2019). In
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TABLE 2 | Results of the detection of the 15 vancomycin-resistant Enterococcus faecium strains on chromID® VRE at different incubation time points on the WASPLab
compared to WASP-based automated inoculation coupled to conventional incubation and manual diagnostic.
Strain ID (vancomycin
MIC)
Negative rectal
ESwabs spiked by
(CFU/ml)
Approx. cells
inoculated on
chromID®VRE (CFU)
WASP coupled to conventional
incubation and manual diagnostic
WASPLab
Incubation time points Incubation time points
24 h 48 h 18 h 24 h 30 h 36 h 40 h 48 h
NARA-89 (4 mg/l) 3.00E + 07 1.00E + 06 + + + + + + + +
3.00E + 06 1.00E + 05 + + + + + + + +
3.00E + 05 1.00E + 04 + + + + + + + +
3.00E + 04 1.00E + 03 – + – + + + + +
3.00E + 03 1.00E + 02 – + – + + + + +
3.00E + 02 1.00E + 01 – + – – + + + +
NARA-388 (16 mg/l) 3.00E + 07 1.00E + 06 + + + + + + + +
3.00E + 06 1.00E + 05 + + + + + + + +
3.00E + 05 1.00E + 04 + + + + + + + +
3.00E + 04 1.00E + 03 – + – + + + + +
3.00E + 03 1.00E + 02 – + – + + + + +
3.00E + 02 1.00E + 01 – + – – + + + +
NARA-490 (64 mg/l) 3.00E + 07 1.00E + 06 + + + + + + + +
3.00E + 06 1.00E + 05 + + + + + + + +
3.00E + 05 1.00E + 04 – + + + + + + +
3.00E + 04 1.00E + 03 – + – – + + + +
3.00E + 03 1.00E + 02 – + – – + + + +
3.00E + 02 1.00E + 01 – – – – – – – –
NARA-491 (96 mg/l) 3.00E + 07 1.00E + 06 + + + + + + + +
3.00E + 06 1.00E + 05 + + + + + + + +
3.00E + 05 1.00E + 04 + + + + + + + +
3.00E + 04 1.00E + 03 + + + + + + + +
3.00E + 03 1.00E + 02 – + – – + + + +
3.00E + 02 1.00E + 01 – + – – + + + +
NARA-492 (8 mg/l) 3.00E + 07 1.00E + 06 + + + + + + + +
3.00E + 06 1.00E + 05 – + – + + + + +
3.00E + 05 1.00E + 04 – + – + + + + +
3.00E + 04 1.00E + 03 – + – + + + + +
3.00E + 03 1.00E + 02 – + – + + + + +
3.00E + 02 1.00E + 01 – – – – – – – –
The 10 HUG VRE strains
(MICs range 32 – >256
mg/l)
3.00E + 07 1.00E + 06 + + + + + + + +
3.00E + 06 1.00E + 05 + + + + + + + +
3.00E + 05 1.00E + 04 + + + + + + + +
3.00E + 04 1.00E + 03 + + + + + + + +
3.00E + 03 1.00E + 02 + + + + + + + +
3.00E + 02 1.00E + 01 + + + + + + + +
the United States, 35.5% of all Enterococcus isolated in health
care-acquired infections are resistant to vancomycin (Sievert
et al., 2013).
To prevent VRE outbreaks, screening of patients at risk
and implementation of isolation precaution is recommended
by different guidelines (Siegel et al., 2007; Frakking et al.,
2018). Screening relies on culture using chromogenic VRE plates
coupled (or not) with the detection of vanA or vanB genes by
PCR. According to different published PCR-based screening for
VRE assays, the sensitivity for the detection of vanA gene ranged
from 43.5 to 100% and the specificity ranged from 79.2 to 99.6%.
However, the detection of the vanB gene has very low specificity,
putatively due to the presence of the vanB gene in anaerobic
bacteria (Mak et al., 2009; Werner et al., 2011; Holzknecht et al.,
2017). Many routine clinical laboratories use different systems
for PCR-based screening for VRE (e.g., GeneXpert, Amplex. . . ).
Nowadays these systems are still marginally more expensive
than cultures.
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FIGURE 1 | (A) Etest results for NARA-490 (a) and NARA-491 (b) strains with satellite colonies growing in the inhibition zone of vancomycin. (B) Vancomycin
population analysis profiles for a fully susceptible (ATCC 35667), fully resistant (ATCC 51858), and heteroresistant strains (NARA-490 and NARA-491) to vancomycin.
Besides the two strains exhibiting vancomycin
heteroresistance, all the other 13 VRE strains included in
this study were detected as early as 24 h on the WASPLab even
if the inoculum was low (3 × 103 CFU/ml), confirming that
30 h was a conservative time point for finalizing the analysis
of chromogenic cultures. However, when the vancomycin
MICs were high, all strains were detected as early as at 18 h,
although the bacterial growth was lower when compared to 24 h
of incubation.
The detection of VRE strains exhibiting low vancomycin
MICs is more challenging. However, our results highlight
that the WASPLab coupled to chromogenic media enables
rapid diagnosis of VRE, by detecting the presence or
conversely ruling out the carriage at 24 and 30 h, respectively.
Overall, for all the 15 different VRE strains included in
this study, automation permitted substantial reduction
of the incubation time without affecting the analytical
sensitivity as compared to WASP-based automated
inoculation coupled to conventional incubation and
manual diagnostic.
The potential limitation of this study relates to the fact
that we analyzed spiked negative rectal ESwabs, but we
managed to include a large range of vancomycin MICs (from
4 up to >256 mg/l), including locally prevalent strains and
heteroresistant strains, to assess the performances using serial
dilutions. Further studies using large series of clinical samples are
still required.
CONCLUSION
Overall, this study shows that the use of the WASPLab coupled
to a VRE-chromogenic medium reliably decreases the time
before the availability of VRE culture results. Our results suggest
to define an early incubation time at 18 h, an intermediate
time at 24 h and a final incubation period of 30 h for VRE
culture screening, to prevent transmission and to reduce
unnecessary cohorting.
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